tavapadon

AbbVie’s $8.7bn Parkinson’s disease drug shines in Phase III trial
Clinical Trials Arena
Mon, 09/30/24 - 09:15 am
AbbVie
Parkinson's Disease
tavapadon
clinical trials
AbbVie's Parkinson's disease drug meets main goal in late-stage trial
Reuters
Thu, 09/26/24 - 11:21 am
AbbVie
Parkinson's Disease
clinical trials
tavapadon
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
BioPharma Dive
Thu, 04/18/24 - 11:09 am
Cerevel Therapeutics
Parkinson's Disease
tavapadon
Cerevel Therapeutics Announces Strategic $125 Million Non-Dilutive Financing Transaction for Tavapadon
BioSpace
Tue, 04/13/21 - 10:17 am
Cerevel Therapeutics
Parkinson's Disease
tavapadon
Bain Capital
Novaquest
Cerevel plots first late-stage move as Pfizer drug comes through in PhII Parkinson's trial
Endpoints
Tue, 09/24/19 - 11:08 am
Cerevel Therapeutics
Pfizer
clinical trials
Parkinson's Disease
tavapadon